Does Dr. JESSICA ACOSTA-VAN DEN BERG have financial conflicts of interest?

Dr. JESSICA ACOSTA-VAN DEN BERG (APRN-CNP) has received a total of $275 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $275 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JESSICA ACOSTA-VAN DEN BERG?

According to CMS Open Payments data, Dr. JESSICA ACOSTA-VAN DEN BERG received funding from BOSTON SCIENTIFIC CORPORATION ($222) and BIOHAVEN PHARMACEUTICAL HOLDING COMPANY ($53).

Does Dr. JESSICA ACOSTA-VAN DEN BERG receive research grants or speaking fees?

Dr. JESSICA ACOSTA-VAN DEN BERG has received $275 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JESSICA ACOSTA-VAN DEN BERG

APRN-CNPReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: CLINTON, OK 73601

NPI Number: 1922404888

LIFETIME INDUSTRY VALUE

$275

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ACOSTA-VAN DEN BERG is a verified Nurse Practitioner, Family practitioner based in CLINTON, OK.

Between 2021 and 2025, Dr. ACOSTA-VAN DEN BERG had an overall industry promotional and research financial footprint of $275 as recorded in the federal CMS Open Payments database.

$275 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACOSTA-VAN DEN BERG's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $222 (representing 80.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$222

80.9%

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY

Rank 2

$53

19.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.